⸺ Celvora
Semaglutide
Synthetic analogue of the GLP-1 hormone used in research to study glucose regulation, insulin secretion and the incretin response.
Secure checkout. Free shipping on orders over £100.
Independently tested
COA on request
Fast dispatch
Order before 2pm
Research use only
Not for human consumption
⸺ Overview
About Semaglutide
Semaglutide is a long-acting GLP-1 receptor agonist used extensively in preclinical and clinical research.
⸺ Mechanism of Action
How it works
Semaglutide binds the GLP-1 receptor, prompting glucose-dependent insulin secretion, suppressing glucagon release and slowing gastric emptying.
⸺ Research
Areas of study
Glycaemic control
Rodent and primate studies have demonstrated improved fasting and post-prandial glucose levels.
Weight regulation
Animal models consistently show reduced food intake and body-weight changes.
Cardio-metabolic markers
Preclinical work has explored changes in lipid panels and inflammatory markers.
⸺ Details
Specification
- CAS
- 910463-68-2
- Intended use
- For research purposes only.
- Storage
- Lyophilised: cool, dry. Reconstituted: 2–8°C.
- Solubility
- Vial holds up to 3mL.
- Shelf life
- Lyophilised: up to 24 months.
- Handling
- Maintain aseptic technique.
You might also research
View all →
Retatrutide
Investigational triple receptor agonist targeting GLP-1, GIP and glucagon — studied for appetite control, energy expenditure and glucose balance.
Tirzepatide
Dual GLP-1 and GIP receptor agonist studied in preclinical models for glucose regulation, insulin sensitivity and energy balance.
Cagrilintide
Long-acting amylin analogue researched for appetite regulation and weight management, often paired with GLP-1 agonists.